Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Small intestine carcinoma
ADR ID BADD_A08198
ADR Hierarchy
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.01      Malignant intestinal neoplasms
07.21.01.016      Small intestine carcinoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.13      Small intestinal neoplasms malignant
16.13.13.002      Small intestine carcinoma
Description Tumors or cancer of the DUODENUM. [MeSH]
MedDRA Code 10054184
MeSH ID D004379; D007580
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Carcinoma duodenum | Carcinoma duodenum resectable | Duodenal cancer | Duodenal cancer non-resectable | Duodenal cancer NOS | Duodenal cancer resectable | Duodenal carcinoma | Duodenal carcinoma non-resectable | Duodenal carcinoma NOS | Jejunal cancer | Jejunal cancer non-resectable | Jejunal cancer NOS | Jejunal cancer resectable | Jejunum cancer | Jejunum cancer non-resectable | Jejunum cancer NOS | Jejunum cancer resectable | Malignant ileal neoplasm | Malignant ileal neoplasm non-resectable | Malignant ileal neoplasm NOS | Malignant ileal neoplasm resectable | Malignant neoplasm of duodenum | Malignant neoplasm of duodenum non-resectable | Malignant neoplasm of duodenum NOS | Malignant neoplasm of duodenum resectable | Malignant neoplasm of ileum | Malignant neoplasm of ileum non-resectable | Malignant neoplasm of ileum NOS | Malignant neoplasm of ileum resectable | Malignant neoplasm of jejunum | Malignant neoplasm of jejunum non-resectable | Malignant neoplasm of jejunum NOS | Malignant neoplasm of jejunum resectable | Malignant neoplasm of Meckel's diverticulum | Malignant neoplasm of Meckel's diverticulum non-resectable | Malignant neoplasm of Meckel's diverticulum NOS | Malignant neoplasm of Meckel's diverticulum resectable | Malignant neoplasm of other specified sites of small intestine | Malignant neoplasm of small intestine, including duodenum | Malignant neoplasm of small intestine, including duodenum non-resectable | Malignant neoplasm of small intestine, including duodenum resectable | Malignant neoplasm of small intestine, unspecified | Malignant neoplasm of small intestine, unspecified non-resectable | Malignant neoplasm of small intestine, unspecified resectable | Malignant small intestinal neoplasm non-resectable NOS | Malignant small intestinal neoplasm NOS | Malignant small intestinal neoplasm resectable NOS | Periampullary carcinoma non-resectable | Periampullary carcinoma NOS | Periampullary carcinoma resectable | Small intestine cancer (excl sarcoma and lymphoma) | Small intestine carcinoma non-resectable | Small intestine carcinoma NOS | Small intestine carcinoma resectable | Small intestine carcinoma | Malignant neoplasm of small intestine, incl duodenum | Malignant neoplasm of small intestine, incl duodenum non-resectable | Malignant neoplasm of small intestine, incl duodenum resectable | Duodenal Neoplasms | Duodenal Neoplasm | Neoplasm, Duodenal | Neoplasms, Duodenal | Duodenal Cancer | Cancer, Duodenal | Cancer of the Duodenum | Cancer of Duodenum | Duodenum Cancer
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00151Apixaban0.000043%
BADD_D00349Capecitabine0.000112%
BADD_D00858Everolimus0.000153%
BADD_D01834Prednisone--
BADD_D01913Ranitidine0.000975%
BADD_D01954Rivaroxaban0.000095%
BADD_D02029Sitagliptin0.000080%
BADD_D02236Tofacitinib0.000362%
The 1th Page    1    Total 1 Pages